Sym004 Versus TAS-102 in Patients With mCRC

NCT03717038 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study was withdrawn due to administrative reasons

Conditions

Interventions

Sponsor

Symphogen A/S